![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Alteration of Hepatic OATP Activity Does Not Alter the Pharmacodynamic Effect of GS-0976, a Liver-Targeted ACC Inhibitor, on De Novo Lipogenesis
|
|
|
Reported by Jules Levin
AASLD 2018, November 9-13 San Francisco, CA
Brian J. Kirby, Justin D. Lutz, Kimberly L. Garrison, Adrianne Vesterdahl, Mun Sang Yue, Ann Ran-Ran Qin, Robert P. Myers, Brian P. Kearney, Anita Mathias - Gilead Sciences, Inc., Foster City, CA
![1207181](../images%20/120718/120718-8/1207181.gif)
![1207182](../images%20/120718/120718-8/1207182.gif)
![1207183](../images%20/120718/120718-8/1207183.gif)
![1207184](../images%20/120718/120718-8/1207184.gif)
![1207185](../images%20/120718/120718-8/1207185.gif)
![1207186](../images%20/120718/120718-8/1207186.gif)
![1207187](../images%20/120718/120718-8/1207187.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|